Post by alanmar1on Apr 03, 2022 4:21pm
476 Views
Post# 34571480
acasti
acastiCredability at work.This stock has not yet met any significant forcast.Carepre was badly promoted and the real reason it failed has never been fully ex[plained.Later the promise of licensing Care pre was abig plus that has come to noithing,How can you believe anything that is said,The delivery systems appear to have promise but no information what the products will cost before the new delivery systems work,If the delivery systems are a success I would expect the drug makers want a big share of the profits,We need positive consistent information before the shares will reflect a higher value.